Free Trial

Jazz Pharmaceuticals (JAZZ) Earnings Date, Estimates & Call Transcripts

$108.13
-0.88 (-0.81%)
(As of 12:58 PM ET)

Earnings Summary

Upcoming
Earnings Date
Jul. 31
After Market Closes
Confirmed
Actual EPS
(May. 1)
$1.98 Missed By -$1.55
Consensus EPS
(May. 1)
$3.53
Skip Charts & View Estimated and Actual Earnings Data

JAZZ Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

JAZZ Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Jazz Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$3.24$3.60$3.42 
Q2 20242$3.68$4.23$3.96 
Q3 20242$3.95$4.52$4.24 
Q4 20241$4.17$4.17$4.17 
FY 20247$15.04$16.52$15.78 
Q1 20251$3.64$3.64$3.64 
Q2 20251$3.89$3.89$3.89 
Q3 20251$4.06$4.06$4.06 
Q4 20251$4.31$4.31$4.31 
FY 20254$15.90$15.90 $15.90

JAZZ Earnings Date and Information

Jazz Pharmaceuticals last posted its quarterly earnings data on May 1st, 2024. The specialty pharmaceutical company reported $1.98 earnings per share for the quarter, missing the consensus estimate of $3.53 by $1.55. The business earned $901.98 million during the quarter, compared to analyst estimates of $938.99 million. Jazz Pharmaceuticals has generated $4.85 earnings per share over the last year ($4.85 diluted earnings per share) and currently has a price-to-earnings ratio of 22.4. Earnings for Jazz Pharmaceuticals are expected to grow by 17.69% in the coming year, from $15.32 to $18.03 per share. Jazz Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Wednesday, July 31st, 2024. Jazz Pharmaceuticals will be holding an earnings conference call on Wednesday, July 31st at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Jazz Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/31/2024
(Confirmed)
-------  
5/1/2024Q1 2024$3.53$1.98($1.55)$4.19$938.99 million$901.98 million
2/28/2024Q4 2023$4.44$4.40($0.04)$7.38$1.01 billion$1.01 billion    
11/8/2023Q3 2023$4.21$4.22+$0.01$6.30$969.47 million$972.14 million
8/9/2023Q2 2023$3.68$3.83+$0.15$6.14$952.44 million$957.32 million
5/10/2023Q1 2023$3.58$3.20($0.38)$5.36$898.11 million$892.81 million
3/1/2023Q4 2022-($0.84)($0.84)$2.14$972.70 million$972.12 million
11/9/2022Q3 2022$4.35$4.53+$0.18$9.37$939.88 million$940.65 million
8/3/2022Q2 2022$3.63$3.62($0.01)$6.69$908.23 million$932.88 million
5/4/2022Q1 2022$3.00$3.13+$0.13$6.23$853.73 million$813.72 million      
3/1/2022Q4 2021$2.98$3.66+$0.68$7.89$866.71 million$896.73 million  
11/9/2021Q3 2021$2.60$4.20+$1.60$8.14$829.98 million$838.12 million    
8/3/2021Q2 2021$3.08$3.90+$0.82$12.69$743.19 million$751.81 million    
5/4/2021Q1 2021$3.09$3.92+$0.83$4.75$613.07 million$607.58 million  
2/23/2021Q4 2020$3.58$4.00+$0.42$4.79$639.83 million$665.52 million    
11/2/2020Q3 2020$4.08$4.31+$0.23$5.08$577.62 million$600.90 million    
8/4/2020Q2 2020$3.11$3.71+$0.60$4.46$503.19 million$562.44 million    
5/5/2020Q1 2020$0.21$0.45+$0.24$2.72$544.55 million$534.73 million  
2/25/2020Q4 2019$3.61$4.42+$0.81$6.79$545.12 million$581.70 million    
11/5/2019Q3$3.19$4.10+$0.91$5.52$523.92 million$537.70 million    
8/6/2019Q2$3.16$3.65+$0.49$2.74$507.23 million$534.13 million    

Jazz Pharmaceuticals Earnings - Frequently Asked Questions

When is Jazz Pharmaceuticals's earnings date?

Jazz Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Wednesday, July 31st, 2024. Learn more on JAZZ's earnings history.

What guidance has Jazz Pharmaceuticals issued on next quarter's earnings?

Jazz Pharmaceuticals issued an update on its FY 2024 earnings guidance on Wednesday, May, 1st. The company provided earnings per share (EPS) guidance of 18.150-19.350 for the period, compared to the consensus estimate of 18.930. The company issued revenue guidance of $4.0 billion-$4.2 billion, compared to the consensus revenue estimate of $4.1 billion.

Did Jazz Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ) missed the analysts' consensus estimate of $3.53 by $1.55 with a reported earnings per share (EPS) of $1.98. Learn more on analysts' earnings estimate vs. JAZZ's actual earnings.

How much revenue does Jazz Pharmaceuticals generate each year?

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded annual revenue of $3.83 billion.

How much profit does Jazz Pharmaceuticals generate each year?

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded net income of $414.83 million. JAZZ has generated $4.85 earnings per share over the last four quarters.

What is Jazz Pharmaceuticals's price-to-earnings ratio?

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a trailing price-to-earnings ratio of 22.36 and a forward price-to-earnings ratio of 7.08. The price/earnings-to-growth ratio is 1.68.

What is Jazz Pharmaceuticals's EPS forecast for next year?

Jazz Pharmaceuticals's earnings are expected to grow from $15.32 per share to $18.03 per share in the next year, which is a 17.69% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:JAZZ) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners